Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats

Fig. 6

Histopathological observations (prostatic tissue stained with Hematoxylin & Eosin, magnification X150) showing effects of BBR and Fin on BPH. Prostate tissue of the BPH group showed morphological abnormalities in the prostate epithelial (as identified by enhanced thickness of epithelial and multiple unorganized layers (white arrow), and numerous intra-glandular lumen papillary folds (black arrow). BBR treatment improved prostatic hyperplasia. BBR (25 and 50 mg/kg) and Fin treatment improved BPH. Con Control, BPH Benign prostatic hyperplasia, Fin Finasteride BBR Berberine

Back to article page